Medicines (MDCO) 10-Q2011 Q1 Quarterly report

Filed: 10 May 11, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Good

New words: acknowledged, add, advisory, angioplasty, aortic, area, argument, artery, Bioniche, bleeding, bribery, build, cardiothoracic, carotid, catheterization, China, compound, Cutler, deemed, default, deviation, dissection, Dorr, Dr, earlier, ease, enhanced, equal, equipment, equivalent, exhausted, filtration, firm, formula, Gland, GmbH, graft, Hale, heard, India, inequitable, internationally, intracranial, investigational, jeopardized, jurisdiction, LLP, master, movement, multiple, Mylan, neurocritical, Northern, ordinary, overturned, peripheral, Pickering, portion, power, PPACA, pretrial, prevailing, prohibited, prohibition, PTCA, reaction, Reddy, repair, restarted, ruled, run, Russia, Satisfaction, scale, scrutiny, settled, slightly, SPA, statutory, stroke, Supreme, transluminal, Turkey, unavailable, unclean, uncured, undertook, unpredictable, unsatisfactory, upheld, validation, validly, valve, vancomycin, weaken, weakening, Wilmer, WilmerHale

Removed: adjusted, annualized, apply, applying, approach, assembled, assumed, beginning, beneficiary, bill, biopharmaceutical, bullet, capitalized, carried, chose, closing, complicated, convenient, cooperating, core, create, cSSSI, deposited, description, difficile, direct, disagree, domestic, Eagle, earned, efficiently, elimination, employed, enrolled, EU, evidence, explore, external, fee, fit, flow, forecast, foregone, forma, goal, hired, identifiable, improving, indefinite, indirect, infusion, insufficiently, InterMune, introduced, lack, launch, legislative, lived, noncash, noncompetitive, obligated, observational, observed, ofClostridium, onForm, outplacement, parent, payable, persuasive, pro, project, pronouncement, realize, reassessment, reclassified, recognized, rejection, relate, relocation, repaid, respond, resupplying, routine, showed, simultaneously, stated, stream, superseded, sweeping, tangible, topic, treat, variable, voting, weighting, withdrew, write

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

MDCO similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of The Medicines Company (the “Company”) for the period ended March 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Glenn P. Sblendorio, Executive Vice President and Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:


(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



		By:	/s/ Glenn P. Sblendorio
			Glenn P. Sblendorio
			Executive Vice President and Chief Financial Officer
Dated:	May 10, 2011

A signed original of this written statement required by Section 906 has been provided to The Medicines Company and will be retained by The Medicines Company and furnished to the SEC or its staff upon request